is jardiance a glp 1 drug GLP-1 Agonists - What it? Jardiance (empagliflozin): Uses, Side Effects,
Description
Lehrke M, Marx N, Patel S, et al
Its December 5, 2017 approval as once weekly Ozempic for diabetes provided potent glycemic control and significant weight loss in a convenient weekly injection
So, maybe some of these uses will end up being good, but we need to study them first. Further study is also necessary for potential long-term adverse events

Phase 2 trials published in the New England Journal of Medicine showed the 12 mg dose group losing 24.2% of body weight at 48 weeks

This is how much longerseven days vs